Skip to main content

Table 4 Multivariate analysis for luminal types (IDC, ILC)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

  DFS OS
Variables HR (95 % CI) P-value HR (95 % CI) P-value
Age     
50 1.0   1.0  
  < 50 1.32(0.88–1.99) 0.176 1.60(0.79–3.25) 0.184
Tumor size     
  < 2 1.0   1.0  
 2 ≤ T < 5 2.35(1.49–3.71)   3.85(1.79–8.26)  
 5≥ 4.04(2.11–7.73) <0.001 5.84(1.65–14.15) <0.001
Lymph node status     
 Negative 1.0   1.0  
 Positive 2.28(1.37–3.79) 0.001 3.06(1.39–8.15) 0.010
Pathology type     
 IDC 1.0   1.0  
 ILC 2.49(1.28–4.85) 0.009 1.90(0.63–5.74) 0.262
Histological grade     
 1 1.0   1.0  
 2 1.77(1.01–3.10)   1.51(0.58–3.91)  
 3 2.31(1.22–4.38) 0.009 2.44(0.87–6.81) 0.060
Endocrine therapy     
 No 1.0   1.0  
 Yes 0.40(0.25–0.70) 0.002 0.35(0.15–0.82) 0.017
Chemotherapy     
 No 1.0   1.0  
 Yes 1.29(0.74–2.25) 0.320 1.02(0.42–2.50) 0.745
  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma DFS disease free survival, OS overall survival, HR hazard ratio, 95%CI 95 % confidence interval